ArticleLeukemia research reports2024

Long-term follow-up of efficacy and safety in elderly patients with chronic myeloid leukemia treated with intermittent low dose dasatinib therapy.

Masahiro Imamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.